These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9502581)

  • 1. Efficient selection of scFv antibody phage by adsorption to in situ expressed antigens in tissue sections.
    Tordsson J; Abrahmsén L; Kalland T; Ljung C; Ingvar C; Brodin T
    J Immunol Methods; 1997 Dec; 210(1):11-23. PubMed ID: 9502581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved helper phage system for efficient isolation of specific antibody molecules in phage display.
    Baek H; Suk KH; Kim YH; Cha S
    Nucleic Acids Res; 2002 Mar; 30(5):e18. PubMed ID: 11861923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model systems to study the parameters determining the success of phage antibody selections on complex antigens.
    Mutuberria R; Hoogenboom HR; van der Linden E; de Bruïne AP; Roovers RC
    J Immunol Methods; 1999 Dec; 231(1-2):65-81. PubMed ID: 10648928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
    Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
    Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A3--a novel colon and pancreatic cancer reactive antibody from a primate phage library selected using intact tumour cells.
    Tordsson J; Lavasani S; Ohlsson L; Karlström P; Svedberg H; Abrahmsén L; Brodin T
    Int J Cancer; 2000 Aug; 87(4):559-68. PubMed ID: 10918198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective phage infection mediated by epitope expression on F pilus.
    Malmborg AC; Söderlind E; Frost L; Borrebaeck CA
    J Mol Biol; 1997 Oct; 273(3):544-51. PubMed ID: 9356245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma.
    Tordsson JM; Ohlsson LG; Abrahmsén LB; Karlström PJ; Lando PA; Brodin TN
    Cancer Immunol Immunother; 2000 Mar; 48(12):691-702. PubMed ID: 10752477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of scFv selected by phage display using detection of scFv-pIII fusion proteins in a microtiter scale assay.
    Mersmann M; Schmidt A; Tesar M; Schöneberg A; Welschof M; Kipriyanov S; Terness P; Little M; Pfizenmaier K; Moosmayer D
    J Immunol Methods; 1998 Nov; 220(1-2):51-8. PubMed ID: 9839925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody.
    Roovers RC; van der Linden E; de Bruïne AP; Arends JW; Hoogenboom HR
    Cancer Immunol Immunother; 2001 Mar; 50(1):51-9. PubMed ID: 11315510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment.
    Willuda J; Honegger A; Waibel R; Schubiger PA; Stahel R; Zangemeister-Wittke U; Plückthun A
    Cancer Res; 1999 Nov; 59(22):5758-67. PubMed ID: 10582696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of human tumor-associated cell surface antigen-binding scFvs.
    Noronha EJ; Wang X; Ferrone S
    Methods Mol Biol; 2002; 178():227-33. PubMed ID: 11968492
    [No Abstract]   [Full Text] [Related]  

  • 12. Combinatorial antibodies against human malignant melanoma.
    Pereira S; Van Belle P; Elder D; Maruyama H; Jacob L; Sivanandham M; Wallack M; Siegel D; Herlyn D
    Hybridoma; 1997 Feb; 16(1):11-6. PubMed ID: 9085122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.
    Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M
    Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of valency in the selection of anti-carbohydrate single-chain Fvs from phage display libraries.
    MacKenzie R; To R
    J Immunol Methods; 1998 Nov; 220(1-2):39-49. PubMed ID: 9839924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of human scFv antibody fragments against ABO blood group antigens from a phage display library.
    Santos-Esteban E; Curiel-Quesada E
    Vox Sang; 2001 Oct; 81(3):194-8. PubMed ID: 11703864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.
    Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B
    PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting.
    Roovers RC; Henderikx P; Helfrich W; van der Linden E; Reurs A; de Bruïne AP; Arends JW; de Leij L; Hoogenboom HR
    Br J Cancer; 1998 Dec; 78(11):1407-16. PubMed ID: 9836471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens.
    Kupsch JM; Tidman N; Bishop JA; McKay I; Leigh I; Crowe JS
    Melanoma Res; 1995 Dec; 5(6):403-11. PubMed ID: 8589614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput generation and engineering of recombinant human antibodies.
    Krebs B; Rauchenberger R; Reiffert S; Rothe C; Tesar M; Thomassen E; Cao M; Dreier T; Fischer D; Höss A; Inge L; Knappik A; Marget M; Pack P; Meng XQ; Schier R; Söhlemann P; Winter J; Wölle J; Kretzschmar T
    J Immunol Methods; 2001 Aug; 254(1-2):67-84. PubMed ID: 11406154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From EST to IHC: human antibody pipeline for target research.
    Frisch C; Brocks B; Ostendorp R; Hoess A; von Rüden T; Kretzschmar T
    J Immunol Methods; 2003 Apr; 275(1-2):203-12. PubMed ID: 12667684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.